Skip to content

ASTELLAS PHARMA

Active Risk: not assessed
Foreign entityfounded 199432 yrs activeSYLVIUSWEG 62, 2333 BE LEIDEN, NetherlandsKBO/BCE: BE 0451.827.087
Summary

For the legal form of ASTELLAS PHARMA, Checked does not compute a bankruptcy probability. The company has been active since 1994 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Risk analysisWatch ReportCompare
ASTELLAS PHARMAActive
Risk analysis ReportCompare

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460NACE 51460
1 site
Size
Accounts not processed yet
Financial health
No score: no figuresProbability: legal form outside the model
Structure
Accounts 1435 d overdue1 of 12 deeds read
Signals- Two or more financial years not filed- Filed more than 90 days lateShow the evidence

Signals

Two signals. The signal on the left, the evidence on the right.
+raises risk
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-03-2022, 4 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 10 filings
Position against the passed deadline
31-03-2022 close31-10-2022 deadline05-10-2026 today
raises risk · Filed more than 90 days late
The financial year that closed on 31-03-2021 was due by 31-10-2021 and was filed on 19-12-2022, 414 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
NBB · 10 filings
Deviation from the deadline
2025
not filed
2024
not filed
2023
not filed
2022
not filed
2021
414 d late
2020
299 d late
2019
228 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 314 days after the deadline; the sector median for financial year 2024 is 3 days before the deadline, and 39% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Resignation: Mark Andree Dekker (managing director)Appointment: Aurelie Partouche (managing director)…
  2. Annual accounts filedfiscal year 2021 · unclassified…
  3. Annual accounts filedfiscal year 2020 · unclassified…

Key points

  • Risk: Accounts not fileddeadline was 31-10-2022 1435 d late View
  • Board changedlatest change 15-01-2026 · 0 in office 1 joined · 1 left View
  • Active since 1994founded 04-02-1994 32 years View

By topic

Timeline

Events
11
Since
2012
  1. 27-02-2026Resignation: Mark Andree Dekker (managing director)
  2. 19-12-2022Annual accounts filed
  3. 26-08-2021Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Foreign entity
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
04-02-1994
Year ends
31-03
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies What held for this company on a given day: board, seat, name?Company as of a date

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure